Aktualności
RAPS: EU Regulation Requires New Safety Features on Drug Packaging by 2019
17.02.2016
A new regulation will require prescription drugmakers in all but three EU countries to incorporate new safety features on their product packaging by 9 February 2019. ...
RAPS: Zika: FDA Recommends Deferring At-Risk Blood Donors for Four Weeks
17.02.2016
The US Food and Drug Administration (FDA) is recommending blood banks defer donations from recent travelers to Zika-affected countries. The recommendation comes in the form of a new guidance
...
URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 16, 2015 on the support which European experts will provide in the context of the global response to the growing epidemi
17.02.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 16, 2015 on the support which European experts
...
URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 16, 2015 on on the malfunctioning analyzer INR used in the study ROCKET
17.02.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 16, 2015 on on the malfunctioning analyzer INR
...
EMA: Draft concept paper on guidance on statistical principles for clinical trials for immunological veterinary medicinal products
29.01.2016
A guideline on statistical principles for veterinary clinical trials for veterinary medicinal products (pharmaceuticals) (EMA/CVMP/EWP/81976/2010) was adopted in 2012. This guideline provides
...
EMA: First specific replacement therapy to treat rare bleeding disorder
29.01.2016
Coagadex recommended for approval for prevention of bleeding episodes for patients with factor X deficiency
The European Medicines Agency (EMA) has recommended granting a marketing authorisation
...
RAPS: FDA Approves First Drug to Improve Overall Survival in Liposarcoma
29.01.2016
FDA Approves First Drug to Improve Overall Survival in Liposarcoma
The US Food and Drug Administration (FDA) on Thursday approved a new indication for Eisai\'s Halaven (eribulin mesylate) to
...
RAPS: CFDA Begins Overseas Inspections
29.01.2016
CFDA Warns Indian, Japanese Manufacturers as Overseas Inspection Drive Begins
China Food and Drug Administration (CFDA) has found fault with the manufacturing practices of four foreign
...
URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of January 12, 2015 concerning the consequences of the loss of news tips published in the European Commission document,, Manual of D
29.01.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of January 12, 2015 concerning the consequences of the loss
...
FDA: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products
11.01.2016
We, FDA, are providing you, establishments that make donor eligibility determinations for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps), with recommendations
...
